This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
New drug triggers rapid cell death in cancer models By Karen Zusi-Tran October 29, 2024 Breadcrumb Home New drug triggers rapid cell death in cancer models BRD-810 inhibits the MCL1 protein and reactivates apoptosis in tumor cells, displaying therapeutic potential in animal models. By Karen Zusi-Tran October 29, 2024 Credit: National Cancer Institute Human cells with acute myelocytic leukemia (AML) in the pericardial fluid.
Paleobiologists have found that the sinuses of ocean dwelling relatives of modern-day crocodiles prevented them from evolving into deep divers like whales and dolphins.
TUESDAY, Oct. 29, 2024 -- Artificial intelligence might be able to help doctors detect the prostate cancers most likely to be life-threatening to men, a new study suggests. An AI program successfully identified and outlined 85% of the most.
Researchers used laser-guided imaging to uncover vast unexplored Maya settlements in Campeche, Mexico, revealing more than 6,500 pre-Hispanic structures, including a previously unknown large city with stone pyramids. Their study enhances our understanding of the ancient civilization's extent and complexity in an area largely overlooked by archaeologists.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
TUESDAY, Oct. 29, 2024 -- Middle-aged folks facing a colon cancer screening now have a blood test they can choose over a standard colonoscopy.However, the blood test isn't as effective as colonoscopy at detecting and preventing colon cancer, a new.
In the largest predation event ever recorded, researchers observed capelin shoaling off the coast of Norway, where a swarm of cod overtook them, consuming over 10 million fish in a few hours. The team hopes to deploy their technique to monitor the large-scale dynamics among other species of fish and track vulnerable keystone species.
Signup to get articles personalized to your interests!
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
In the largest predation event ever recorded, researchers observed capelin shoaling off the coast of Norway, where a swarm of cod overtook them, consuming over 10 million fish in a few hours. The team hopes to deploy their technique to monitor the large-scale dynamics among other species of fish and track vulnerable keystone species.
Daniel Quirk, an immunology and neuroscience executive at Bristol Myers Squibb, will be Biogen’s next chief medical officer, while Robin Kramer will replace retiring CFO Michael McDonnell.
Military musicians returning from the Napoleonic wars established Britain's first brass bands earlier than previously thought, new research reveals. The study undermines the idea that brass bands were a civilian and exclusively northern creation.
TUESDAY, Oct. 29, 2024 -- For many reasons, bodybuilders and others involved in weight training might have to take a break from the gym.However, new Finnish research finds that even weeks-long interruptions in training won't hamper muscle-building.
The licensing deal with China’s Chimagen Biosciences is the latest example of drugmaker interest in exploring the potential of “T cell engagers” in autoimmune disease.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
TUESDAY, Oct. 29, 2024 -- Artificial intelligence can accurately detect heart murmurs in dogs, a new study finds.The AI program detects heart murmurs in canines with 90% accuracy, similar to the accuracy of expert cardiologists, researchers.
TUESDAY, Oct. 29, 2024 -- Health officials are investigating the case of an Iowa resident who died of Lassa fever after traveling recently to West Africa.The Ebola-like virus is rarely seen in the United States, according to the U.S. Centers for.
Crescent Biopharma is advancing a drug its CEO claims is “purpose-built” to be a perfected version of Summit Therapeutics’ ivonescimab, which recently beat Merck’s Keytruda in a Phase 3 trial.
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
TUESDAY, Oct. 29, 2024 -- Researchers looking at the sweltering European summer of 2022 estimated that more than half of the heat-linked deaths occurring on the continent would not have happened if human-led climate change wasn't in place."Without.
TUESDAY, Oct. 29, 2024 -- Weed use among U.S. teenagers fell dramatically over the past decade, a new study shows.By 2021, only about 16% of teens said they were currently using marijuana, down from 23% in 2011, researchers found.All grades.
Addgene is very excited to share the very first edition of our Antibodies 101 eBook! The latest addition to our eBook collection is a handy resource for anyone looking to use antibody-based applications in their research.
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
TUESDAY, Oct. 29, 2024 -- Most kids with attention issues won't go on to develop serious psychiatric conditions like psychosis or schizophrenia. However, a new study finds poor attention spans in childhood, plus certain genes, could play a role in.
What if a microbe could help curb the climate crisis? Meet UTEX-3222, aka 'Chonkus,' a cyanobacterium discovered living in the volcanic CO2 seeps off the coast of Vulcano, Sicily. Chonkus is like other photosynthetic cyanobacteria in that it consumes CO2 and incorporates it into its cells. However, what sets UTEX-3222 apart is its rapid, high-density growth, which allows it to consume CO?
PBSS - San Francisco Bay—Current State of Bioanalysis for Biologics and Cell/Gene Therapy Products iianiro Tue, 10/29/2024 - 20:55 Image foster_city_sunset.
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Paleontologists have identified fossils of an ancient species of bug that spent the past 450 million years covered in fool's gold in central New York. The new species, Lomankus edgecombei, is a distant relative of modern-day horseshoe crabs, scorpions, and spiders. It had no eyes, and its small front appendages were best suited for rooting around in dark ocean sediment, back when what is now New York state was covered by water.
PBSS - San Francisco Bay—Clinical Pharmacology Studies on Hepatic and Renal Impairments for NDA Filing iianiro Tue, 10/29/2024 - 16:53 Image gettyimages-1330763893-640x640.
Weddell seals in Erebus Bay, Antarctica, may look like couch potatoes when they are resting on ice. However, these seals, which are the southernmost population of the southernmost living mammals, are exceptional divers that can reach depths of more than 900 meters and recorded dives lasting 96 minutes, which is well beyond their aerobic threshold. Scientists have identified an optimal and novel dive foraging strategy the seals employ to capture prey in the highly seasonal Antarctic environment w
PBSS - Boston—Preclinical Development and IND Filing for new modalities, ADCs, SiRNA/ASO, Gene and Cell Therapies iianiro Tue, 10/29/2024 - 18:14 Image cambridge-massachusetts.
In the rapidly evolving landscape of biotechnology and pharmaceutical development, contract development and manufacturing organizations (CDMOs) have become essential partners for companies seeking to bring innovative medicines to market. However, navigating the complexities of these partnerships can be daunting, especially for smaller biotech companies.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
133 
Let's personalize your content